7 of the biggest pharma bankruptcies this year
Here’s a look at the biggest bankruptcies in pharma this year.
Two pharma companies admit to price-fixing
King Pharma and Alissa Healthcare Research admitted to illegal collusion.
King Pharma and Alissa Healthcare Research admitted to illegal collusion.
Akcea’s top three execs depart
Akcea Therapeutics has announced the immediate departure of its CEO, president and COO.
Biocon nabs Pfizer R&D facility
Biocon Biologics has acquired R&D capital assets for a 60,000 square foot bench-to-pilot scale biologics research facility.
Novartis shifts Zolgensma manipulation blame
Novartis has now placed the blame for the Zolgensma data manipulation onto the former executives of AveXis.